RSS

NHS

Following a series of papers, published in The Lancet and featuring contributions from Professor Martin Underwood of Warwick Medical School, the NHS has published recommended changes to the treatment of low back pain. more

News

Innovate UK, the country’s innovation agency, has awarded a grant to Aseptika and Zenzium for the development of a new home-based early warning system, using artificial intelligence (AI), for people with severe respiratory disease. more

News

London-based scientists have found a new blood test that may be able to quickly predict if a female patient is responding to the breast cancer drug, palbociclib, earlier that is possible with currently available tests. more

Technology

A new version of the model Clinical Trials Agreement (mCTA), aimed at speeding up clinical trials and medicines research, has been welcomed by life science leaders across the whole of the UK, according to the ABPI more

News

A final appraisal determination (FAD) has been issued by the National Institute for Health and Care Excellence (NICE), recommending routine NHS use of avelumab for the treatment of adults in England, Wales and Northern Ireland with mMCC more

News

A recent study has revealed that an estimated 237 million medication errors occur in the NHS in England yearly, which, in addition to avoidable adverse drug reactions (ADRs), account for many avoidable deaths. more

News

NHS funded initiative, SBRI Healthcare, has revealed its latest round of development awards, with 10 companies set to share a £1 million investment to develop innovations for high potential cancer screening solutions. more

News

The MedTalk Podcast returns with its first episode of 2018, looking at the biggest and most topical news of the year so far in the digital health, pharma, medical plastics and med-tech spaces. more

Opinion

Administration of quadrivalent flu jabs should be on the agenda for the NHS as fourth flu strain, known as ‘Japanese flu’ is becoming most prevalent in Europe, according to data and analytics company, GlobalData. more

Opinion

The Brexit Health Alliance (BHA) has urged for regulatory arrangements to be made as a matter of urgency to prevent any potential risk to public health as a result of Brexit. more

Analysis

After speaking openly about her brain cancer, the former minister for public health and culture secretary, Tessa Jowell, is now campaigning for cancer patients to have the choice to trial new treatments and stop the ones that aren’t working for them more

News

The Northern Health Science Alliance (NHSA) has been named as the government’s partner to deliver the Life Sciences Industrial Strategy sector deal across the North of England. more

News

Patients suffering with cancer and severe mental illness are being hit by drug shortages, costing the NHS £180 million in half a year, according a report published by The Times. more

News

Yesterday (Wednesday 6 December) saw the announcement of a sector deal by the government with the life sciences sector which should bring substantial global investment into the sector to ensure continued innovation and highly-skilled job creation more

News

The Competition and Markets Authority (CMA) has released a statement alleging that drug company, Concordia, has abused its position with the NHS to overcharge for liothyronine tablets — an essential thyroid drug. more

News

In this online exclusive, Hitesh Dodhia, superintendent pharmacist at PharmacyOutlet.co.uk, looks at what the forthcoming government budget announcement should set out for pharma and healthcare in the current challenging political landscape. more

Opinion

Two life-extending drugs will now be available to breast cancer patients on the NHS after price negotiations lead the National Institute for Health and Care Excellence (NICE) to approve them. more

News

Cherwell Laboratories has announced its support of two national pharmaceutical manufacturing conferences this month, which are both marking 25 year anniversaries. more

News

In response to the latest government comment on the accelerated access scheme, the BioIndustry Association’s CEO Steve Bates has released a statement confirming the support of this important agenda by the association. more

News

The controversy surrounding Avastin and Lucentis has reared its head again as it has been revealed that health chiefs may face a legal fight if they go ahead with plans to offer the cheaper drug (Avastin) to patients with wet AMD on the NHS more

News